IGFBP3 and metabolic dysfunction-associated steatohepatitis: ↓ IGF-1/intact IGFBP-3 ratio in NASH patients with fibrosis as compared to in controls with milder or no histologic lesions in the liverAfter performing a binary logistic regression, the IGF-1/intact IGFBP-3 ratio did not remain robustly associated with NASH or liver fibrosis (unadjusted and after adjusting for BMI and age)